Literature DB >> 28099872

Assessment of gait and sensorimotor deficits in the D1CT-7 mouse model of Tourette syndrome.

Stephen C Fowler1, Laura J Mosher2, Sean C Godar3, Marco Bortolato3.   

Abstract

Tourette syndrome (TS) is a neurodevelopmental disorder characterized by multiple motor and phonic tics. While TS patients have been also shown to exhibit subtle abnormalities of sensorimotor integration and gait, animal models of this disorder are seldom tested for these functions. To fill this gap, we assessed gait and sensorimotor integration in the D1CT-7 mouse, one of the best-validated animal models of TS. D1CT-7 mice exhibit spontaneous tic-like manifestations, which, in line with the clinical phenomenology of TS, are markedly exacerbated by environmental stress. Thus, to verify whether stress may affect sensorimotor integration and gait functions in D1CT-7 mice, we subjected these animals to a 20-min session of spatial confinement, an environmental stressor that was recently shown to worsen tic-like manifestations. Immediately following this manipulation (or no confinement, for controls), animals were subjected to either the sticky-tape task, to test for sensorimotor integration; or a 60-min session in an open field (42×42cm) force-plate actometer for gait analysis. Gait analyses included spatial, temporal, and dynamic (force) parameters. D1CT-7 mice displayed a longer latency to remove a sticky tape, indicating marked impairments in sensorimotor integration; furthermore, these mutants exhibited shortened stride length, increased stride rate, nearly equal early-phase velocity, and higher late-phase velocity. D1CT-7 mice also ran with greater force amplitude than wild-type (WT) littermates. None of these phenotypes was worsened by spatial confinement. These results highlight the potential importance of testing sensorimotor integration and gait functions as a phenotypic correlate of cortical connectivity deficits in animal models of TS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Gait; Sensorimotor integration; Tourette syndrome

Mesh:

Year:  2017        PMID: 28099872      PMCID: PMC5511586          DOI: 10.1016/j.jneumeth.2017.01.009

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  35 in total

1.  Glucocorticoids and mammalian motor nerve excitability.

Authors:  W F Riker; T Baker; M Okamoto
Journal:  Arch Neurol       Date:  1975-10

2.  Sensory Phenomena in Tourette Syndrome: Their Role in Symptom Formation and Treatment.

Authors:  David C Houghton; Matthew R Capriotti; Christine A Conelea; Douglas W Woods
Journal:  Curr Dev Disord Rep       Date:  2014-12

3.  Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior.

Authors:  M J McGrath; K M Campbell; M B Veldman; F H Burton
Journal:  Behav Pharmacol       Date:  1999-09       Impact factor: 2.293

4.  A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.

Authors:  E J Nordstrom; F H Burton
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

5.  Dynamic regulation of sensorimotor integration in human postural control.

Authors:  Robert J Peterka; Patrick J Loughlin
Journal:  J Neurophysiol       Date:  2003-09-17       Impact factor: 2.714

6.  Obsessive compulsive behaviour and depressive symptoms in young people with Tourette syndrome. A controlled study.

Authors:  Mary M Robertson; Sube Banerjee; Valsamma Eapen; Paul Fox-Hiley
Journal:  Eur Child Adolesc Psychiatry       Date:  2002-12       Impact factor: 4.785

7.  "Hyperglutamatergic cortico-striato-thalamo-cortical circuit" breaker drugs alleviate tics in a transgenic circuit model of Tourette׳s syndrome.

Authors:  Eric J Nordstrom; Katie C Bittner; Michael J McGrath; Clinton R Parks; Frank H Burton
Journal:  Brain Res       Date:  2015-10-08       Impact factor: 3.252

8.  Sensorimotor control of gait: a novel approach for the study of the interplay of visual and proprioceptive feedback.

Authors:  Ryan Frost; Jeffrey Skidmore; Marco Santello; Panagiotis Artemiadis
Journal:  Front Hum Neurosci       Date:  2015-02-09       Impact factor: 3.169

9.  Postural control anomalies in children with Tourette syndrome.

Authors:  M Lemay; N Termoz; P Lesperance; S Chouinard; G A Rouleau; F Richer
Journal:  Exp Brain Res       Date:  2007-03-07       Impact factor: 2.064

Review 10.  Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.

Authors:  Daniël Lakens
Journal:  Front Psychol       Date:  2013-11-26
View more
  6 in total

1.  Behavioral fragmentation in the D1CT-7 mouse model of Tourette's syndrome.

Authors:  Andrea Santangelo; Marco Bortolato; Laura J Mosher; Giuseppe Crescimanno; Giuseppe Di Giovanni; Emanuele Cassioli; Valdo Ricca; Maurizio Casarrubea
Journal:  CNS Neurosci Ther       Date:  2018-01-03       Impact factor: 5.243

2.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 3.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

4.  Allopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models.

Authors:  Laura J Mosher; Sean C Godar; Marianela Nelson; Stephen C Fowler; Graziano Pinna; Marco Bortolato
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

5.  Tourette syndrome research highlights from 2017.

Authors:  Andreas Hartmann; Yulia Worbe; Kevin J Black
Journal:  F1000Res       Date:  2018-07-23

6.  Conditional knockout of UBC13 produces disturbances in gait and spontaneous locomotion and exploration in mice.

Authors:  David F Wozniak; Pamela Valnegri; Joshua T Dearborn; Stephen C Fowler; Azad Bonni
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.